Health Care & Life Sciences » Pharmaceuticals | Proteomics International Laboratories Ltd.

Proteomics International Laboratories Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
476.10
608.40
816.80
925.40
1,176.50
Cost of Goods Sold (COGS) incl. D&A
948.50
1,056.30
1,896.60
2,280.00
2,506.70
Gross Income
472.40
447.90
1,079.80
1,354.60
1,330.30
SG&A Expense
399.60
428.10
575.30
422.90
1,017.40
EBIT
872.10
876.00
1,655.10
1,777.50
2,347.70
Unusual Expense
-
560.00
-
-
-
Non Operating Income/Expense
655.20
44.00
247.30
119.90
98.60
Interest Expense
34.30
48.10
32.50
65.00
61.70
Pretax Income
251.20
1,440.00
1,900.70
1,707.20
2,284.20
Income Tax
-
290.80
572.30
790.80
844.10
Consolidated Net Income
251.20
1,149.20
1,328.50
916.50
1,440.10
Net Income
251.20
1,149.20
1,328.50
916.50
1,440.10
Net Income After Extraordinaries
251.20
1,149.20
1,328.50
916.50
1,440.10
Net Income Available to Common
251.20
-
1,328.50
916.50
1,440.10
EPS (Basic)
-
0.04
0.03
0.02
0.02
Basic Shares Outstanding
-
26,338.40
50,592.50
55,070.70
60,692.20
EPS (Diluted)
-
-
0.03
0.02
0.02
Diluted Shares Outstanding
-
-
50,592.50
55,070.70
60,692.20
EBITDA
-
873.50
1,652.30
1,612.30
2,112.00
Non-Operating Interest Income
-
-
34.10
15.40
26.60

About Proteomics International Laboratories

View Profile
Address
QEII Medical Centre
Perth Western Australia (WA) 6009
Australia
Employees -
Website http://www.proteomics.com.au
Updated 07/08/2019
Proteomics International Laboratories Ltd. is a biological research and drug discovery company. It operates through three synergistic business units: Analytical services, Diagnostics and Therapeutics. The Analytical services unit engages in contract research, analytical testing and consultancy.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.